Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease

about

Factors associated with the 6-minute walk distance in patients with systemic sclerosis.Computed tomography trachea volumetry in patients with scleroderma: Association with clinical and functional findings

P2860

Q47151670-300859CD-518D-4841-8C9F-98AFA7371619 Q57647977-167FB840-BCE3-45E5-98A8-59EE2D1B79EA

P2860

Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease

Item

http://www.wikidata.org/entity/Q38649246

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Predictors of lung function te ...... ated interstitial lung disease

@en

type

Item

label

Predictors of lung function te ...... ated interstitial lung disease

@en

prefLabel

Predictors of lung function te ...... ated interstitial lung disease

@en

P1476

Predictors of lung function te ...... ated interstitial lung disease

@en

P2093

Alain Duhamel

http://www.w3.org/2001/XMLSchema#string

Anne-Lise Hachulla

http://www.w3.org/2001/XMLSchema#string

Hélène Béhal

http://www.w3.org/2001/XMLSchema#string

Jean-Baptiste Faivre

http://www.w3.org/2001/XMLSchema#string

Martine Remy-Jardin

http://www.w3.org/2001/XMLSchema#string

Noémie Le Gouellec

http://www.w3.org/2001/XMLSchema#string

Pierre-Yves Hatron

http://www.w3.org/2001/XMLSchema#string

Regis Matran

http://www.w3.org/2001/XMLSchema#string

Sandrine Morell-Dubois

http://www.w3.org/2001/XMLSchema#string

Thierry Perez

http://www.w3.org/2001/XMLSchema#string

P2860

Standardisation of the measurement of lung volumes

Standardisation of the single-breath determination of carbon monoxide uptake in the lung

Criteria for the classification of early systemic sclerosis.

Cyclophosphamide versus placebo in scleroderma lung disease.

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.

Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group.

Changes in causes of death in systemic sclerosis, 1972-2002

Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis

Pulmonary complications: one of the most challenging complications of systemic sclerosis.

Diagnosis and classification of systemic sclerosis.

P304

e0181692

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0181692

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David Launay

Marc Lambert

Eric Hachulla

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28763468

http://www.w3.org/2001/XMLSchema#string

P932

5538660

http://www.w3.org/2001/XMLSchema#string

Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease

about

P2860

P2860

Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932